ACTRN12609000259246
Completed
Phase 3
A double-blind randomised controlled study of the anti-inflammatory effects of azithromycin 250mg daily for 12 weeks in adults with symptomatic neutrophilic airway disease
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- Hunter New England Area Health Service
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Symptomatic stable asthma or Chronic Obstructive Pulmonary Disease (COPD), increased sputum neutrophils.
Exclusion Criteria
- •Hypersensitivity to macrolides, other respiratory disease, taking macrolide, tetracycline, antibiotic or oral corticosteroid in past month, taking antacid treatment, taking medication that prolongs the heart's corrected QT interval (QTc), current smoking, pregnancy, impaired liver function.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Macrolide treatment of Non-Eosinophilic AsthmaACTRN12605000318684Hunter New England Area Health Service64
Completed
Not Applicable
A randomised double blind controlled study of the effects of methylphenidate on Central Audition DeficitsCentral Audition Deficit (Central Auditory Processing Disorder [CAPD])Nervous System DiseasesISRCTN35253389niversity of Western Ontario (Canada)62
Recruiting
Not Applicable
A randomized, double-blind controlled study of the efficacy of infrared-whole body hyperthermia in patients with major depressioF32.1F32.2F33.1F33.2Moderate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsDRKS00015754Klinik für Psychiatrie und PsychotherapieCharité Campus Mitte82
Completed
Phase 2
Vitamin D supplementation for the treatment of Behcet's diseaseBehcet's disease.Behçet diseaseIRCT201212216975N4Vice chancellor for research, Tabriz University of Medical Sciences50
Recruiting
Phase 1
A randomized double-blind controlled study on the efficacy and safety of Sangdanzhongfeng granule in the treatment of post-stroke spasticityITMCTR2100004617Hunan Academy of Chinese Medicine Affiliated Hospital